No better than control. Possibly worse, it seems.
Azithromycin still absolutely required, though.
Next.
First hydroxychloroquine randomized controlled trial reads out with a disappointing viral clearance rate of 87% vs 93% control arm.
Unfortunately not what we needed right now but hopes that in a more severe population we will see something
H/t Umer Raffat + team @ ISI pic.twitter.com/1qCIhToYLx
— GC (@gcbioinv) March 24, 2020